Create embed code
Total aid by recipient type
Health policy and administrative management
WHO has applied for a voluntary contribution to their Programme Budget 2018-209 (PB2018-2019) for the implementation of all results which make an integral part of WHOs GPW 2014-2019 as well as the first year of the coming GPW (GPW2019-2013). The proposed intervention is a contiuation of previous support to WHO's PB 2016-2017. The overarching strategic document that will guide the use of Sida’s support to WHO during the period 2018-2019 is first and foremost GPW2019-2023 (ie GPW13). GPW’s in general are translated into reality through the process of programme budgeting which involves Member States, the Secretariat’s leadership team and staff across the Organization. The programme budget sets out do give a more digestable, snap-shot of what WHO plans to do with the resources available, what results that are to be achieved. However, since GPW13 begins on January 1, 2019, the biennual programme budget cycle is not in line with the GPW cycle since the first Programme Budget under the new GPW will cover the years 2020-2021 (whereas GPW covers 2019-2023) which means year 2019 will be considered as a transition year where WHO will begin to track GPW13-implementation yet at the same time, as part of their accountability for 2018/2019, will be reporting on PB 2018/2019 as required by Member States. PB2018-2019 defines working priorities for the following categories and programmes: communicable diseases, noncommunicable diseases, promoting health through the life course, health systems, WHO Health Emergencies programme, corporate services/enabling functions and polio eradication. The proposed support for the PB 2018-2019 is 320 MSEK, same amount has the previous period 2016-17 but a reduction of approximately 6% (20MSEK) in relation to 2014-2015. The total budget for the PB 2018-2019 is 4421.5 MUSD (approximately 36,4 billion SEK), an increase of 1% in relation to 2016-2017. Sida’s core voluntary support to WHO constitutes approximately 38,9 MUSD, which corresponds to approximately 0.8% of the total budget. The total share of fully flexible non-earmarked contributions to WHO represents only 3% of WHO's total budget. WHO' is the global normsetting actor in the area of health and the UN normative agency for health issues with the mandate to lead and coordinate global health work and support Member States governments in the implementation of the best possible healthcare-policy. SDG3 forms the basis for WHO's work. WHO's new workplan (GPW13) is structured around three interconnected strategic priorities to ensure healty lives and well-being for all at all ages; advancing universal health coverage, addressing health emergencies and promoting healthier populations. These strategic priorities are supported by three strategic shifts: stepping up leadership; driving impact in every country; and focusing global public goods on impact -which reflect WHO's six core functions (for more details see p6 GPW13). More specifically, in response to the challenge to "leave no-one behind, GPW13 sets ambitious goals of 1 billion people for earch of its strategic priorities i.e. 1 billion more people enjoying better health and well-being; 1 billion more people better protected from health emergencies; 1 billion more people benefitting from universal health coverage. In line with Agenda2030 all 1-billion-targets are to be achieved in year 2030. As mentioned, the basis for WHO's work för WHO’s arbete utgörs av SDG-mål 3 that is Ensure healthy lives and promote wellbeing for all at all ages. in line with GPW13, the WHO focuses on promoting health rather than fighting disease, in particular among vulnerable groups and with a focus of health equity. During the planned agreement period Sida intends to follow-up on a selection of indicators from the PB2018-2019 as well as some indicators linked to GPW13. WHO has been strongly engaged in the UN-reform aimed at working as ”One-UN” in order to improve UN’s capability to deliver in a coordinated ma
Swedish International Development Cooperation Agency
International Vaccine Institute, established in 1997 is a multilateral research institute, which develops vaccines in order to reduce the burden of diarrheal and respiratoral diseases in low-income countries. IVI offers technical assistance to vaccine producers and regulators in the developing world, and mantain an international network of collaborating research institutions.
Swedish International Development Cooperation Agency
|Year||Value (SEK)||Value (USD)|
|2020||SEK 300 m||USD 31.7 m|
|2019||SEK 178 m||USD 18.8 m|
|2018||SEK 165 m||USD 19.0 m|
|2017||SEK 175 m||USD 20.4 m|
|2016||SEK 167 m||USD 19.5 m|
|2015||SEK 176 m||USD 20.9 m|
|2014||SEK 170 m||USD 24.8 m|
|2013||SEK 468 m||USD 71.9 m|
|2011||SEK 630 m||USD 97.1 m|
|2009||SEK 70,0 m||USD 9.2 m|
|2008||SEK 70,0 m||USD 10.5 m|
Multilateral core support is a non-earmarked support to multilateral organisations such as the EU, UN, the World Bank, regional development banks and global foundations. This means that the organisation’s board (which Sweden is usually a part of) decides how the funds are to be used.
Health sector policy, public health administration, education, training and research, laboratories, clinics, hospitals and ambulances. Dental sevices, mental care, drug and substance abuse control, and medical rehabilitation.
No results, please try another dataset.